Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

No Surprises Act and You (Published in the SCMS Winter 2022 Newsletter)

Client Alert

Originally posted in the Stark County Medical Society Winter 2022 Newsletter.

Legislation has been adopted by the United States Congress and the Ohio Legislature known as the “No Surprises Act” which attempts to regulate billing by professionals and facilities to patients who are not in networks with those facilities or providers at those facilities. The federal bill was triggered by some sensational news stories of patients being billed for tens of thousands of dollars for emergency care when the hospital was out of the network under the patient’s insurance plans.

The federal legislation covers all billing for both emergency and nonemergency services at a participating facility which includes a hospital, ambulatory surgical center or critical access hospital. The rules also apply to other unique services such as air ambulance transportation services. The final rules expand the rule to also cover office-based health care providers.

These rules were originally being drafted to cover emergency services in the hospital setting (for example, the pathology group might not be in-network for all plans that the hospital takes). The final rules however indicated that the final rules do in fact apply to office-based practices, including both emergency and non-emergency care.

The federal rules apply if a patient is not insured by a plan accepted by provider, or is a self-pay patient. Self-pay patients include patients who are in fact covered by insurance, but the patient has advised the healthcare provider they do not plan on submitting the claim for coverage under their insurance plan.

For an applicable patient, the physician is required to give the patient a “Good Faith Estimate” (“GFE”) of anticipated cost of the patient’s healthcare service in advance. CMS has created a sample GFE template which requires: (a) patient name and DOB, (b) description of primary services, (c) itemized list of services “reasonably expected” to be furnished, (d) applicable diagnosis codes and expected charges, (e) your NPI, (f) services that may require separate scheduling, (g) disclaimer that this is only an estimate, and (h) patient may use the dispute resolution process. Any actual bill which is $400 over the estimate triggers a patient option to dispute the charges. You may elect to post prices and costs on your website as well. If the service date is ten days out, the GFE must be given three days in advance. If the service date is less than three days in advance, the GFE must be given the day before. Days are counted as business days, not calendar days. The GFE can be for a specific service or a course of treatment, such as $X for 12 sessions. If unexpected matters arise at the visit such as a potential vaccination shot that had not been expected, you are not required to stop the visit and provide a new GFE.

If you fail to provide the GFE, the patient can elect to use the dispute resolution process which is being developed by HHS. No details are finalized other than they have announced there will be an administration fee charged. Penalties for noncompliance have not yet been announced.

In addition to the federal rule, Ohio has also adopted a similar statute that went into effect January 12, 2022 dealing with out-of-network costs.

While there is some question how the federal act will be enforced in a private-practice office setting. In the event you routinely charge out-of-network patients higher rates than that which you may charge for in-network or government patients, you will need to provide certain notice forms to patients so they would be given notice that the rates would be higher than the rate paid by an insurance company or for a self-pay patient, what the costs will be. This is similar in concept to the Advance Beneficiary Notice required for patients covered by Medicare for services which are outside of Medicare coverage. Absent these documents in advance and if the statutes were to apply, you may end up dealing with the federal dispute resolution system and potential penalties per violation. We encourage you to update your office procedures and compliance plans to meet these new rules.

If you have any questions or would like to talk with us concerning updating your office compliance plans in this matter, please contact Scott Sandrock at 330-253-4367, spsandrock@bmdllc.com.


Ohio Board of Pharmacy Update: Key Regulatory Changes and Proposals You Need to Know

The Ohio Board of Pharmacy (BOP) has rescinded certain OAC rules (OAC 4729:5-18-01 through 4729:5-18-06), removing regulations on office-based opioid treatment (OBOT) clinics. The rescissions took effect on June 3, 2024. The BOP also published a new rule, OAC 4729:8-5-01, which sets explicit reporting guidelines for licensed dispensaries and became effective on June 7, 2024.

LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”

Ohio Recovery Housing Overhaul: New Standards and Certification Requirements Reshape Sober Living Spaces

Ensuring Fair Access: SB 269 Protects Affordable Medication for Low-Income Patients

SB 269, introduced on December 19, 2023, will ensure that 340B covered entities, including Federally Qualified Health Centers, Ryan White Clinics, disproportionate share hospitals, and Title X clinics, can acquire 340B drugs without facing undue restrictions or discriminatory practices from drug manufacturers and distributors. This protection is crucial for 340B covered entities to continue to provide affordable medications and comprehensive services to low-income patients.

Unveiling Ohio's Pharmacy Board Updates for Distributors, Mobile Clinics, and Controlled Substances

The Ohio Board of Pharmacy will hold a public hearing on May 28, 2024, to discuss several proposed changes and additions to Ohio Administrative Code (OAC). These changes pertain to terminal distributors of dangerous drugs (TDDDs), mobile clinics or medication units, and the classification of controlled substances.